COMP <GO>
GVH vs TMO // REVENUE GROWTH (YOY)
Globavend Holdings Limited (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GVH 4
— TMO 6
▲ REVENUE GROWTH (YOY) LEADER: GVH
LAST: $0.99 (+8.52%) • MKT CAP: $4.3M
revenue-growth
42.50%
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
revenue-growth
3.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GVH VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GVH | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 10.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 9.30% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.4x | 30.4x | -26.00 | GVH | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | 2.40% | +3.06 | GVH | /fcf-yield <GO> |
| Operating Margin | 4.10% | 17.40% | -13.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 2.90% | 15.10% | -12.20 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 42.50% | 3.90% | +38.60 | GVH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 62.9 | -13.10 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.2x | 36.3x | -31.10 | GVH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.3M | $262.22B | -$262.21B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GVH REV | TMO REV | GVH GROSS % | TMO GROSS % | GVH FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.6M | $44.56B | 10.1% | — | $232.0K | $6.29B |
| FY 2024 | $16.5M | $42.88B | 14.6% | — | -$266.5K | $7.27B |
| FY 2023 | $18.6M | $42.86B | — | — | $2.0M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GVH // BETA —
TMO // BETA 0.94